spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Biolimus 

 HSMN NewsFeed - 9 Mar 2012
Biosensors Makes Organizational Changes to Senior Management Team to Prepare for Continued Growth
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 29 Jul 2010
Devax Receives CE Mark for the AXXESS Drug Eluting Bifurcation Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 19 Mar 2009
XTENT Receives CE Mark Approval for CUSTOM NX (R) Drug-Eluting Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 13 Oct 2008
Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Sep 2008
Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First 'Real World, All Comers' Clinical Study
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Jan 2008
Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Dec 2007
XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 12 Dec 2007
Devax Announces Completion of Enrollment of DIVERGE Trial of Novel Drug- Eluting Stent System for Bifurcation Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Jun 2006
Devax Initiates Enrollment in the DIVERGE Clinical Trial with the AXXESS(TM) Drug Eluting Bifurcation Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
Xtent CUSTOM I Trial Shows Zero Restenosis, Favorable Late Loss Results at Eight Months
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Mar 2006
Xtent CUSTOM I Trial Shows Zero Restenosis at Four Months
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Jan 2006
Xtent Customized Stent System Achieves Two Coronary Firsts: Single Catheter Delivers Multiple Stents and Longest Stent Ever Placed
Devices Interventional Cardiology
Return to NewsFeed  

 Additional items found! 10

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 10 additional stories matching:
Biolimus
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.